Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: Calcifying microvesicles as imaging target for plaque characterization

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 767-779

  Wagner, Susanne ^a   Schnorr, Jörg ^a   Ludwig, Antje ^a   Stangl, Verena ^a   Ebert, Monika ^a   Hamm, Bernd ^a   Taupitz, Matthias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Calcifying microvesicles; Glycosaminoglycans; Inflammation; Iron oxide nanoparticles; Magnetic resonance imaging

Indexed keywords

ALCIAN BLUE; GLYCOSAMINOGLYCAN; MAGNESIUM CHLORIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EX VIVO STUDY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MICROVASCULATURE; NONHUMAN; RABBIT; SIGNAL DETECTION; SIGNAL INTENSITY; SIGNAL LOSS; SIGNAL PROCESSING; STAINING;

ATHEROSCLEROSIS; CALCIFYING MICROVESICLES; GLYCOSAMINOGLYCANS; INFLAMMATION; IRON OXIDE NANOPARTICLES; MAGNETIC RESONANCE IMAGING;

ANIMALS; AORTA; ATHEROSCLEROSIS; COLORING AGENTS; CONTRAST MEDIA; CYTOPLASMIC VESICLES; FERROCYANIDES; HYPERLIPIDEMIAS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; PHANTOMS, IMAGING; PLAQUE, ATHEROSCLEROTIC; RABBITS; TUNICA INTIMA;

EID: 84874448775     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38702     Document Type: Article

References (37)

1. Schmitz SA, Coupland SE, Gust R, et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol. 2000;35(8):460-471.
2. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103(3):415-422.
3. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107(19):2453-2458.
4. Trivedi RA, U-King-Im JM, Graves MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke. 2004;35(7):1631-1635.
5. Sigovan M, Boussel L, Sulaiman A, et al. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology. 2009;252(2):401-409.
6. Sigovan M, Kaye E, Lancelot E, et al. Anti-inflammatory drug evaluation in ApoE-/-mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Invest Radiol. 2012;47(9):546-552.
7. Jarrett BR, Correa C, Ma KL, Louie AY. In vivo mapping of vascular inflammation using multimodal imaging. PLoS One. 2010;5(10): e13254.
8. Morishige K, Kacher DF, Libby P, et al. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation. 2010; 122(17):1707-1715.
9. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7(2):77-86.
10. Rogers WJ, Basu P. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis. 2005;178(1):67-73.
11. Tang TY, Patterson AJ, Miller SR, et al. Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques. Neuroradiology. 2009;51(7):457-465.
12. Makowski MR, Varma G, Wiethoff AJ, et al. Noninvasive assessment of atherosclerotic plaque progression in ApoE-/-mice using susceptibility gradient mapping. Circ Cardiovasc Imaging. 2011;4(3):295-303.
13. Morris JB, Olzinski AR, Bernard RE, et al. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol. 2008;28(2):265-271.
14. Wilhelm C, Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials. 2008;29(22):3161-3174.
15. Fleige G, Seeberger F, Laux D, et al. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest Radiol. 2002;37(9):482-488.
16. Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 1999;99(3):348-353.
17. Li X, Kramer MC, van der Loos CM, et al. A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. Atherosclerosis. 2011;218(1):83-89.
18. Bobryshev YV, Killingsworth MC, Lord RS, Grabs AJ. Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture. J Cell Mol Med. 2008;12(5B):2073-2082.
19. Hsu HH, Camacho NC, Tawfik O, Sun F. Induction of calcification in rabbit aortas by high cholesterol diets: roles of calcifiable vesicles in dystrophic calcification. Atherosclerosis. 2002;161(1):85-94.
20. Taupitz M, Wagner S, Schnorr J, et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol. 2004;39(7):394-405.
21. Wagner M, Wagner S, Schnorr J, et al. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: Initial experience in humans. J Magn Reson Imaging. 2011;34(4):816-823.
22. Wagner S, Schnorr J, Pilgrimm H, Hamm B, Taupitz M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol. 2002;37(4):167-177.
23. Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie. 1965;5(3):221-233.
24. López D, Durán AC, Fernández MC, Guerrero A, Arqué JM, Sans-Coma V. Formation of cartilage in aortic valves of Syrian hamsters. Ann Anat. 2004;186(1):75-82.
25. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92(5):1355-1374.
26. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262-1275.
27. Puchtler H, Meloan SN, Terry MS. On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem. 1969;17(2):110-124.
28. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging. 1994; 4(3):301-307.
29. Li W, Ostblom M, Xu LH, et al. Cytocidal effects of atheromatous plaque components: the death zone revisited. FASEB J. 2006;20(13): 2281-2290.
30. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97(23):2307-2315.
31. Duer MJ, Friscić T, Proudfoot D, et al. Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol. 2008;28(11):2030-2034.
32. Wexler BC, Judd JT, Kittinger GW. Changes in calcium, hydroxyproline and mucopolysaccharides in various aortic segments of arteriosclerotic breeder rats. J Atheroscler Res. 1963;4:397-415.
33. Schnorr J, Wagner S, Abramjuk C, et al. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs. Invest Radiol. 2004;39(9):546-553.
34. Taupitz M, Schnorr J, Wagner S, et al. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. Radiology. 2002;222(1):120-126.
35. Warmuth C, Schnorr J, Kaufels N, et al. Whole-heart coronary magnetic resonance angiography: contrast-enhanced high-resolution, time-resolved 3D imaging. Invest Radiol. 2007;42(8):550-557.
36. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92(5):1355-1374.
37. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262-1275.